Incannex appoints experienced lead investigators for sleep apnoea clinical trial
Incannex Healthcare has recruited two highly experienced leaders for its clinical trial investigating IHL-42X cannabinoid treatment of obstructive sleep apnoea. Incannex Healthcare has recruited two highly experienced lead principal investigators (PIs) for the IND opening Phase-2/3 clinical trial investigating IHL-42X cannabinoid treatment of obstructive sleep apnoea (OSA). The company has appointed Dr John D Hudson … [Read more…]